Mia's Feed
Medical News & Research

New AI-Driven System Aims to Improve Detection of Life-Threatening Respiratory Syndrome

New AI-Driven System Aims to Improve Detection of Life-Threatening Respiratory Syndrome

Share this article

A new AI-based system developed by researchers aims to improve the detection of Acute Respiratory Distress Syndrome (ARDS), a life-threatening lung condition, enhancing early diagnosis and treatment in critical care settings.

2 min read

Researchers from Endeavor Health and Northwestern University have developed an advanced artificial intelligence (AI) tool designed to assist healthcare professionals in identifying a severe and often underdiagnosed respiratory condition known as Acute Respiratory Distress Syndrome (ARDS). This innovative system analyzes existing patient data, including laboratory results and imaging, to flag potential cases, thereby supporting early diagnosis and treatment.

ARDS occurs when the lungs become intensely inflamed, leading to fluid leakage into the air sacs and preventing oxygen from entering the bloodstream. Often described as "drowning on dry land," this condition results from immune system leakage rather than an infection, and it carries a high mortality rate of nearly 46%. Survivors frequently suffer from long-term lung scarring or cognitive impairments due to oxygen deprivation.

The AI tool has already demonstrated impressive accuracy, correctly identifying 93% of historical ARDS cases. While it does not replace clinical judgment, it functions as a decision support system—alerting physicians to the possibility of ARDS based on patients' medical records. The next phase involves testing the system's ability to predict ARDS in current hospital patients, potentially enabling preemptive interventions.

Dr. Curtis Weiss, a pulmonologist involved in the project, emphasized that ARDS is often missed because its symptoms overlap with other conditions and because clinicians face information overload during ICU shifts. Accurate identification is critical, as treatment strategies differ significantly from those used for conditions like congestive heart failure, which can present similar symptoms.

The AI's design ensures it does not generate false information but rather synthesizes available data for better clinical insights. For example, recognizing the correct cause of lung fluid accumulation can inform whether a ventilator needs to be adjusted or whether different supportive measures are necessary.

The tool's development addresses the challenge of underdiagnosis, which can delay essential treatments. By assisting physicians in integrating multiple diagnostic indicators, the AI system aims to improve ARDS detection rates, ultimately saving more lives.

The research team plans to refine the tool further to minimize false positives, focusing on ensuring that patients at real risk are prioritized for care. This innovative approach signifies a significant step forward in critical care management, leveraging AI to enhance diagnosis accuracy and patient outcomes.

Source: https://medicalxpress.com/news/2025-08-ai-tool-dangerous-respiratory-syndrome.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Prenatal Testosterone Exposure Influences Children’s Activity Levels and Muscle Strength at Age 7

Research shows that prenatal testosterone exposure affects boys' activity levels and girls' muscle strength by age 7, highlighting the impact of maternal health conditions like PCOS.

Impact of Neighborhood Marginalization on Outcomes After Heart Attack in Young Adults

Living in socioeconomically marginalized neighborhoods is associated with higher mortality and reduced healthcare follow-up in young acute myocardial infarction survivors, emphasizing the impact of social determinants on heart health outcomes.

Enhancing Blood Cancer Immunotherapy Through Innovative Modification

Brazilian researchers have developed an improved CAR-T cell therapy by inhibiting the PRC2 complex, resulting in more effective treatment for resistant blood cancers such as lymphoma and leukemia.